Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting fees and expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Securities Purchase Agreement
Agreement with institutional investors for 3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected proceeds of approximately $3.9 million before expenses.
Offering Closure
Expected closing date on August 15, 2025, subject to customary conditions.
- The offering signifies a strategic move to raise capital for future operations and initiatives.
- This agreement demonstrates investor confidence in Scienture Holdings, Inc.'s growth potential and market positioning.
This securities purchase agreement marks a significant step for Scienture Holdings, Inc. in securing funding for its pharmaceutical operations and product development.